2 results
Approved WMORecruiting
Primary:• To compare progression free survival (PFS) between Arm A (ociperlimab in combination with tislelizumab) and Arm B (pembrolizumab followed by placebo) in the Intent to Treat (ITT) Analysis Set as assessed by investigators according to…
Approved WMOPending
The primary objective of this study is to assess whether tacrolimus is effective for the treatment of morphea.